Published in

Nature Research, Nature Communications, 1(5), 2014

DOI: 10.1038/ncomms5051

Links

Tools

Export citation

Search in Google Scholar

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

Journal article published in 2014 by Jingmei Li, Linda S. Lindstroem, Linda S. Lindström, Sajjad Rafiq, Jia N. (Jia) Foo ORCID, Marjanka K. (Marjanka) Schmidt ORCID, M. (Meena) Rafiq, Paul D. P. (Paul) Pharoah, Kyriaki Michailidou, Joe Dennis, Manjeet K. (Manjeet) Bolla, Qin Wang, Laura J. Van ’t Veer, Sten Cornelissen, Emiel J. Rutgers and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Large population-based registry studies have shown that breast cancer prognosis is inherited. Here we analyse single-nucleotide polymorphisms (SNPs) of genes implicated in human immunology and inflammation as candidates for prognostic markers of breast cancer survival involving 1,804 oestrogen receptor (ER)-negative patients treated with chemotherapy (279 events) from 14 European studies in a prior large-scale genotyping experiment, which is part of the Collaborative Oncological Gene-environment Study (COGS) initiative. We carry out replication using Asian COGS samples (n=522, 53 events) and the Prospective Study of Outcomes in Sporadic versus Hereditary breast cancer (POSH) study (n=315, 108 events). Rs4458204-A near CCL20 (2q36.3) is found to be associated with breast cancer-specific death at a genome-wide significant level (n=2,641, 440 events, combined allelic hazard ratio (HR)=1.81 (1.49-2.19); P for trend=1.90 × 10 â ̂'9). Such survival-associated variants can represent ideal targets for tailored therapeutics, and may also enhance our current prognostic prediction capabilities. © 2014 Macmillan Publishers Limited.